NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
NPCE on Nasdaq
Shares outstanding
33,235,472
Price per share
$16.52
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
26,262,179
Total reported value
$405,338,148
% of total 13F portfolios
0%
Share change
+723,286
Value change
+$12,794,322
Number of holders
99
Price from insider filings
$16.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Polar Capital Holdings Plc 9.1% $34,534,675 2,972,003 Polar Capital Holdings Plc 31 Mar 2025
Soleus Private Equity Fund I, L.P. 8.9% $30,496,537 2,957,957 Guy Levy 30 Sep 2025
ORBIMED ADVISORS LLC 8% -23% $26,716,960 -$8,095,783 2,614,184 -23% OrbiMed Advisors LLC 30 Jun 2025
MORGAN STANLEY 8.3% $28,926,723 2,489,391 Morgan Stanley 31 Dec 2024
Soleus Capital Master Fund, L.P. 7% $23,545,122 2,303,828 Soleus Capital Management, L.P. 30 Jun 2025
Kent Lake PR LLC 4.9% -2% $17,227,289 +$116,944 1,482,555 +0.68% Kent Lake PR LLC 31 Dec 2024

As of 31 Dec 2025, 99 institutional investors reported holding 26,262,179 shares of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE). This represents 79% of the company’s total 33,235,472 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Polar Capital Holdings Plc 8.7% 2,878,523 -7.1% 0.2% $44,444,395
Soleus Capital Management, L.P. 8.1% 2,703,208 -8.6% 1.8% $41,737,532
MORGAN STANLEY 7.7% 2,547,784 +0.06% 0% $39,337,784
ORBIMED ADVISORS LLC 7.2% 2,406,335 -8% 0.79% $37,153,812
BlackRock, Inc. 7.2% 2,383,917 -1.4% 0% $36,807,679
Driehaus Capital Management LLC 4.5% 1,511,289 +61% 0.16% $23,334,302
VANGUARD GROUP INC 4.5% 1,482,228 +3.2% 0% $22,885,600
First Light Asset Management, LLC 4.1% 1,349,482 -0.78% 1.6% $20,836,002
DEUTSCHE BANK AG\ 2.8% 929,522 +0.08% 0% $14,351,820
ARMISTICE CAPITAL, LLC 2.4% 792,000 -39% 0.3% $12,228,480
KOTLER KEVIN 1.9% 631,468 0% 7.2% $9,749,866
FMR LLC 1.9% 624,947 +0.1% 0% $9,649,182
GEODE CAPITAL MANAGEMENT, LLC 1.8% 596,248 +6.5% 0% $9,208,225
STATE STREET CORP 1.3% 447,864 +9.8% 0% $6,915,020
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.2% 396,619 +32% 0.04% $6,123,797
Nantahala Capital Management, LLC 0.89% 295,089 0% 0.27% $4,556,174
NORTHERN TRUST CORP 0.7% 231,774 -2% 0% $3,578,591
Walleye Capital LLC 0.69% 228,847 +345% 0.02% $3,533,398
RENAISSANCE TECHNOLOGIES LLC 0.67% 222,300 +72% 0.01% $3,432,312
Palumbo Wealth Management LLC 0.64% 214,175 +8.5% 0.82% $3,306,862
ESSEX INVESTMENT MANAGEMENT CO LLC 0.64% 213,892 -1.3% 0.5% $3,302,492
Qube Research & Technologies Ltd 0.6% 198,997 -6.9% 0% $3,072,514
TUDOR INVESTMENT CORP ET AL 0.58% 193,346 +26% 0.02% $2,985,262
ALGERT GLOBAL LLC 0.52% 172,926 +77% 0.04% $2,670,000
BANK OF AMERICA CORP /DE/ 0.51% 170,439 +196% 0% $2,631,578

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 26,262,179 $405,338,148 +$12,794,322 $15.44 99
2025 Q3 25,945,404 $267,500,978 +$34,175,646 $10.31 80
2025 Q2 22,505,448 $250,711,399 -$19,749,912 $11.14 98
2025 Q1 23,932,784 $294,127,661 +$42,108,506 $12.29 89
2024 Q4 20,868,828 $233,522,000 +$8,990,314 $11.19 61
2024 Q3 14,795,861 $103,125,040 +$1,471,249 $6.97 48
2024 Q2 14,430,601 $109,095,635 +$4,457,712 $7.56 51
2024 Q1 13,364,973 $176,414,273 +$9,053,052 $13.20 53
2023 Q4 12,690,314 $130,836,764 +$2,444,618 $10.31 41
2023 Q3 18,073,997 $175,859,892 +$5,454,271 $9.73 24
2023 Q2 17,503,080 $78,589,150 -$756,243 $4.49 20
2023 Q1 17,670,188 $81,990,736 +$1,754,483 $4.64 24
2022 Q4 17,357,024 $25,862,002 -$2,680,436 $1.49 22
2022 Q3 18,161,017 $68,102,000 -$1,024,177 $3.75 27
2022 Q2 18,426,044 $91,207,000 -$26,340 $4.95 26
2022 Q1 18,210,639 $149,512,180 -$117,404 $8.21 37
2021 Q4 18,012,051 $181,543,000 +$1,949,052 $10.08 41
2021 Q3 11,190,051 $177,393,000 +$509,015 $15.85 39
2021 Q2 10,905,701 $259,451,000 +$259,451,000 $23.79 44